Funder
Sanofi US
Regeneron Pharmaceuticals Inc
Reference25 articles.
1. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the american heart association;Wenger;Circulation,2022
2. Adequate enrollment of women in cardiovascular drug trials and the need for sex-specific assessment and reporting;Carland;American Heart Journal Plus: Cardiology Research and Practice,2022
3. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials;Cholesterol Treatment Trialists;Lancet,2015
4. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society;Roeters van Lennep;Eur Heart J,2023
5. Sex-specific predictors of PCSK9 levels in a European population: the IMPROVE study;Ferri;Atherosclerosis,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献